Note 5 - Shareholders' Equity

9 Months Ended

Jul. 31, 2012

Stockholders' Equity Note Disclosure [Text Block]

5. SHAREHOLDERS’ EQUITY

Common stock repurchases. Our board of directors periodically authorizes us to repurchase shares of our common stock.  As of July 31, 2012, $21.1 million remained outstanding under our board authorization.  We cancel shares that are repurchased.  No shares were repurchased during the three and nine months ended July 31, 2012.  Although we generally prioritize bank debt reduction over share repurchases we may consider share repurchases when there are anomalies in the share value created by, but not limited to, market conditions.

The timing of our common stock repurchases pursuant to our board of directors’ authorization is dependent on future opportunities and on our views, as they may change from time to time, as to the most prudent uses of our capital resources, including cash and borrowing capacity.

Other comprehensive income. For the three and nine months ended July 31, 2012 and 2011, other comprehensive income consisted primarily of foreign currency translation adjustments.  The following table provides information related to other comprehensive income:

	Three Months Ended July 31,						Nine Months Ended July 31,
	2012			2011			2012			2011
	( In thousands)
Net income	$	10,424		$	9,126		$	27,808		$	21,876
Currency translation adjustment		(3,436	)		(2,136	)		(10,538	)		13,965
Total comprehensive income	$	6,988		$	6,990		$	17,270		$	35,841

Comprehensive income consists of two components, net income and other comprehensive income. Other comprehensive income refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of shareholders’ equity but are excluded from net income. The Company’s other comprehensive income consists of foreign currency translation adjustments from those subsidiaries not using the U.S. dollar as their functional currency.

Additional paid in capital.  For the nine months ended July 31, 2012, the activity in additional paid in capital consisted of $16.2 million in proceeds received from stock option exercises and $3.1 million in share-based compensation expense and $0.7 million of related tax effect/benefit from stock option activity.